Occurrence, human exposure, and risk of microplastics in the indoor environment.


Journal

Environmental science. Processes & impacts
ISSN: 2050-7895
Titre abrégé: Environ Sci Process Impacts
Pays: England
ID NLM: 101601576

Informations de publication

Date de publication:
26 Jan 2022
Historique:
pubmed: 30 11 2021
medline: 28 1 2022
entrez: 29 11 2021
Statut: epublish

Résumé

Microplastics (MPs) are a group of emerging contaminants that have attracted increasing scientific and societal attention over the past decade due to their ubiquitous detection in all environmental compartments. So far, most studies on MPs focus on characterizing their occurrence, fate, and impact in the aquatic environment. Therefore, very little is known about the magnitude, patterns, and associated risks of human exposure to MPs, particularly indoors. This is a significant research gap given that people spend most of their time (up to 90%) indoors, which is exacerbated over the past year by COVID-19 lockdown measures. Critical evaluation of the existing literature revealed the presence of MPs at higher concentrations in indoor air and dust (from homes and offices) compared to outdoors. This was attributed to several factors including: indoor MPs sources (

Identifiants

pubmed: 34842877
doi: 10.1039/d1em00301a
doi:

Substances chimiques

Dust 0
Flame Retardants 0
Microplastics 0
Plastics 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

17-31

Auteurs

Hassan Khalid Ageel (HK)

School of Geography, Earth and Environmental Sciences, University of Birmingham, Birmingham B15 2TT, UK. M.abdallah@bham.ac.uk.

Stuart Harrad (S)

School of Geography, Earth and Environmental Sciences, University of Birmingham, Birmingham B15 2TT, UK. M.abdallah@bham.ac.uk.

Mohamed Abou-Elwafa Abdallah (MA)

School of Geography, Earth and Environmental Sciences, University of Birmingham, Birmingham B15 2TT, UK. M.abdallah@bham.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH